Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Frontiers in Oncology|May 20, 2021
Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid LeukemiaNoortje van Gils, Fedor Denkers, Linda SmitTrends in Cell Biology|June 9, 2004
LKB1 tumor suppressor protein: PARtaker in cell polarityAnnette F Baas, Linda Smit, Hans CleversCancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradicationQuinty Hansen, Costa Bachas, Linda Smit, et al.Experimental Hematology|May 1, 2017
Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiationNoortje van Gils, Han J M P Verhagen, Linda SmitCancers|July 1, 2017
Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?Tania Martiáñez Canales, David C de Leeuw, Eline Vermue, et al.The Journal of Biological Chemistry|February 13, 2004
Wnt activates the Tak1/Nemo-like kinase pathwayLinda Smit, Annette Baas, Jeroen Kuipers, et al.Cancers|July 27, 2022
Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination TherapiesMila S Griffioen, David C de Leeuw, Jeroen J W M Janssen, et al.Oncotarget|November 24, 2015
An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiationLinda Smit, Katrien Berns, Katherine Spence, et al.Cancer Research|January 31, 2014
Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradicationDavid C de Leeuw, Fedor Denkers, Marjolein C Olthof, et al.Hemasphere|July 14, 2021
The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor CellsNoortje van Gils, Tania Martiañez Canales, Eline Vermue, et al.Pageof 3